The global market for cell and gene therapy tools and reagents is expected to grow from $12 billion in 2025 and is projected to reach $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.
The North American market for cell and gene therapy tools and reagents is expected to grow from $5.2 billion in 2025 and is projected to reach $9.2 billion by the end of 2030, at a CAGR of 12.1% during the forecast period of 2025 to 2030.
The European market for cell and gene therapy tools and reagents is expected to grow from $3.4 billion in 2025 and is projected to reach $5.6 billion by the end of 2030, at a CAGR of 10.2% during the forecast period of 2025 to 2030.
Report Scope
The report provides an overview of the global market for cell and gene therapy tools and reagents. It includes global revenue ($ millions) for the base year 2024, estimated data for 2025, and forecast data from 2026 through 2030. In this report, the market is segmented based on product type, application and end user. By product type, the market is segmented into vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome (CRS) monitoring, cryopreservation and media.
The application segment covered cancer, rare diseases and other diseases. By end user, the market is divided into pharmaceutical and biotechnology companies, academic research institutes, and clinical laboratories.
The regions covered in this study are North America, Europe, Asia-Pacific and rest of the World (RoW) (which includes the Middle East and Africa and South America), with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the rest of Europe, China, Japan, India, South Korea and the rest of Asia-Pacific. The report covers the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. The report also has a dedicated section of company profiles that covers details of leading companies. It analyzes companies' environmental, social and corporate governance (ESG) initiatives.
Report Includes
- 77 data tables and 55 additional tables
- An overview of the global market for cell and gene therapy tools and reagents
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2025. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
- Evaluation of the current market size and revenue growth prospects specific to the cell and gene therapy tools and reagents market, accompanied by a market share analysis by type, application, end user, and region
- Analysis of current and future demand in the cell and gene therapy tools and reagents market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Discussion of the prevalence of infectious disease, metabolic disorders and chronic ailments, along with the recent technological advances, competitive landscape, and the industry value chain
- Analysis of drivers, challenges, and opportunities affecting market growth
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
- Market share analysis of the key market participants in the industry, along with their research priorities, product portfolios, global rankings and company competitive landscape
- Profiles of major companies within the industry, including Thermo Fisher Scientific Inc., Cytiva (Danaher Corp.), Merck KGaA, Miltenyi Biotec, and Sartorius AG
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Overview
- Current Market Scenario
- Segmental Analysis
- Regional Market Insights
- Emerging Technologies
- Conclusion
Chapter 2 Market Overview
- Cell and Gene Therapy Overview
- Cell Therapy
- Gene Therapy
- Types of Cell and Gene Therapy
- Gene Therapy
- Cell Therapy
- Common Equipment Used
- Approved Cell and Gene Therapy Products
- Macroeconomic Factors Analysis
- Demographic Factors
- Geopolitical Factors
- Impact of U.S. Tariffs
- Porter's Five Forces Analysis
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Increasing Investments in CGT Research
- Expanding Clinical and Commercial CGT Products
- Rising Demand for Precision Medicine
- Capacity Expansions for Clinical and Commercial Manufacturing
- Growing Number of Strategic Initiatives
- Rising Aging Population and the Increasing Prevalence of Chronic Diseases
- Market Restraints/Challenges
- Complex Manufacturing and Supply Chain
- High Cost of Development
- Lack of Skilled Workforce
- Regulatory Hurdles
- Market Opportunities
- Rising Demand for CGTs in Emerging Countries
- Growing Demand for Off-the-Shelf Products
Chapter 4 Regulatory Landscape
- Overview
- U.S.
- Cell Therapy Regulations
- Gene Therapy Regulations
- Viral and Non-Viral Vectors
- Media
- GMP Proteins and Antibodies
- Leukapheresis
- Europe
- Asia-Pacific
Chapter 5 Emerging Technologies and Developments
- Key Takeaways
- Closed and Automated Systems
- Single-Use Technologies and Miniaturization
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis by Product Type
- Key Takeaways
- Immunoassays
- Bioreactors
- Leukapheresis
- GMP Antibodies
- Multiplex Immunoassays
- Vectors
- Cell Separation
- Cryopreservation
- Cell Expansion
- Media
- GMP Proteins
- GMP Small Molecules
- CRS Monitoring
- Market Analysis by Application
- Key Takeaways
- Cancer
- Rare Diseases
- Other Diseases
- Market Analysis by End User
- Key Takeaways
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Clinical Laboratories
- Geographic Breakdown
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Competitive Intelligence
- Key Takeaways
- Competitive Analysis
- Strategic Initiatives
- Agreements, Collaborations and Partnerships
- Acquisitions
- Investments and Expansions
Chapter 8 Sustainability in Global Market for Cell and Gene Therapy Tools and Reagents: An ESG Perspective
- Introduction to ESG
- Sustainability Trends and Company Initiatives
- Environmental Factors
- Social Factors
- Governance Factors
- Social and Governance Initiatives
- Concluding Remarks
Chapter 9 Appendix
- Research Methodology
- Sources
- Abbreviations
- Company Profiles
- ABCAM LTD.
- ADVERUM BIOTECHNOLOGIES INC.
- AKRON BIOTECH
- BIO-RAD LABORATORIES INC.
- BIO-TECHNE
- CYTIVA
- FUJIFILM IRVINE SCIENTIFIC (FUJIFILM BIOSCIENCES)
- MERCK KGAA
- MILTENYI BIOTEC
- PROTEINTECH GROUP INC.
- QIAGEN
- REVVITY
- SARTORIUS AG
- STEMCELL TECHNOLOGIES
- THERMO FISHER SCIENTIFIC INC.
- Emerging Startups/Market Disruptors
